North American Proteomics Reagents Market Research Report
- Report Code: PR 1001
- Publish Date: Upcoming
The North American proteomics reagents market is driven by the increase in collaboration between companies & research institutes and the increasing investments in R&D in this sector. The market was valued at $1.34 million in 2012, and is expected to reach $2.26 billion by 2018, at a CAGR of 8.20%.
The report ‘North American proteomics reagents Market Forecast, 2012-2018’ analyzes the market in terms of product type, such as immunoassay, microarray, spectroscopy, electrophoresis, x-ray crystallography, chromatography, and protein fractionation. These market segments have experienced high growth, owing to an increased awareness for sophisticated diagnostic techniques. The immunoassay segment accounted for the largest share of 31.00% in the overall market, followed by microarray.
In North America, funding for proteomics research from various organizations, increasing agreements and collaboration among large companies, and the increasing investments in R&D are the major driving factors for the proteomics reagents market. The U.S. has the largest share not only in North America but also globally, occupying 33% of the global market.
The report provides an extensive competitive landscaping of the leading companies operating in this market. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Sigma- Aldrich Corporation, and Bio-Rad laboratories.
Furthermore, the details of the segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies are provided in the report.
Customization Options
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- Applications of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Key Data:
- Units of reagents sold in a particular country
- The number of diagnostics labs, research labs, and hospitals where the proteomics reagents are used
Researcher/Scientist’s Perception Analysis:
- Fast turn-around analysis of researchers’ response to market events and trends
- Pattern analysis of usage by researchers
- Researchers’ opinions about products from different companies
Product/Brand Perception Matrix:
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution
Pricing Trends:
- Cost analysis of proteomics reagents in the major countries of the region
Competitive Intelligence:
- The company share analysis of the top players in the market in this region
- The crucial developments and strategies that companies inculcate in their portfolios
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Proteomics Reagents-North America, By Applications
4.1 Split By Geography
4.1 Proteomics Reagents-USA by Applications
4.1 Proteomics Reagents-Canada by Applications
4.2 Proteomics Reagents-Diagnosis-North America
4.2.1 Proteomics Reagents-Diagnosis-North America, By Technologies
4.2.1.1 Proteomics Reagents-Protein Microarray Reagents-North America-Diagnosis
4.2.1.2 Proteomics Reagents-Spectroscopy Reagents-North America-Diagnosis
4.2.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-North America-Diagnosis
4.2.2 Proteomics Reagents-Diagnosis-North America, By Geographies
4.2.2.1 Proteomics Reagents-Canada-Diagnosis
4.2.2.2 Proteomics Reagents-USA-Diagnosis
4.3 Proteomics Reagents-Drug Discovery-North America
4.3.1 Proteomics Reagents-Drug Discovery-North America, By Technologies
4.3.1.1 Proteomics Reagents-Protein Microarray Reagents-North America-Drug Discovery
4.3.1.2 Proteomics Reagents-Spectroscopy Reagents-North America-Drug Discovery
4.3.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-North America-Drug Discovery
4.3.2 Proteomics Reagents-Drug Discovery-North America, By Geographies
4.3.2.1 Proteomics Reagents-Canada-Drug Discovery
4.3.2.2 Proteomics Reagents-USA-Drug Discovery
5 Proteomics Reagents-North America, By Technologies
5.1 Split By Geography
5.2 Proteomics Reagents-USA by Technologies
5.1 Proteomics Reagents-Canada by Technologies
5.2 Proteomics Reagents-Protein Fractionation Reagents-North America
5.2.1 Proteomics Reagents-Protein Fractionation Reagents-North America, By Geographies
5.2.1.1 Proteomics Reagents-Protein Fractionation Reagents-USA
5.2.1.2 Proteomics Reagents-Protein Fractionation Reagents-Canada
5.3 Proteomics Reagents-Spectroscopy Reagents-North America
5.3.1 Proteomics Reagents-Spectroscopy Reagents-North America, By Applications
5.3.1.1 Proteomics Reagents-Spectroscopy Reagents-North America-Drug Discovery
5.3.1.2 Proteomics Reagents-Spectroscopy Reagents-North America-Diagnosis
5.3.2 Proteomics Reagents-Spectroscopy Reagents-North America, By Geographies
5.3.2.1 Proteomics Reagents-Spectroscopy Reagents-USA
5.3.2.2 Proteomics Reagents-Spectroscopy Reagents-Canada
5.4 Proteomics Reagents-Chromatography Reagents-North America
5.4.1 Proteomics Reagents-Chromatography Reagents-North America, By Geographies
5.4.1.1 Proteomics Reagents-Chromatography Reagents-USA
5.4.1.2 Proteomics Reagents-Chromatography Reagents-Canada
5.5 Proteomics Reagents-X-Ray Crystallography Reagents-North America
5.5.1 Proteomics Reagents-X-Ray Crystallography Reagents-North America, By Applications
5.5.1.1 Proteomics Reagents-X-Ray Crystallography Reagents-North America-Drug Discovery
5.5.1.2 Proteomics Reagents-X-Ray Crystallography Reagents-North America-Diagnosis
5.5.2 Proteomics Reagents-X-Ray Crystallography Reagents-North America, By Geographies
5.5.2.1 Proteomics Reagents-X-Ray Crystallography Reagents-USA
5.5.2.2 Proteomics Reagents-X-Ray Crystallography Reagents-Canada
5.6 Proteomics Reagents-Electrophoresis Reagents-North America
5.6.1 Proteomics Reagents-Electrophoresis Reagents-North America, By Geographies
5.6.1.1 Proteomics Reagents-Electrophoresis Reagents-USA
5.6.1.2 Proteomics Reagents-Electrophoresis Reagents-Canada
5.7 Proteomics Reagents-Protein Microarray Reagents-North America
5.7.1 Proteomics Reagents-Protein Microarray Reagents-North America, By Applications
5.7.1.1 Proteomics Reagents-Protein Microarray Reagents-North America-Drug Discovery
5.7.1.2 Proteomics Reagents-Protein Microarray Reagents-North America-Diagnosis
5.7.2 Proteomics Reagents-Protein Microarray Reagents-North America, By Geographies
5.7.2.1 Proteomics Reagents-Protein Microarray Reagents-USA
5.7.2.2 Proteomics Reagents-Protein Microarray Reagents-Canada
5.8 Proteomics Reagents-Immunoassay Reagents-North America
5.8.1 Proteomics Reagents-Immunoassay Reagents-North America, By Geographies
5.8.1.1 Proteomics Reagents-Immunoassay Reagents-USA
5.8.1.2 Proteomics Reagents-Immunoassay Reagents-Canada
6 Proteomics Reagents-North America, By Geographies
6.1 Proteomics Reagents-USA
6.1.1 Proteomics Reagents-USA, By Technologies
6.1.1.1 Proteomics Reagents-Protein Microarray Reagents-USA
6.1.1.2 Proteomics Reagents-Spectroscopy Reagents-USA
6.1.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-USA
6.1.1.4 Proteomics Reagents-Electrophoresis Reagents-USA
6.1.1.5 Proteomics Reagents-Immunoassay Reagents-USA
6.1.1.6 Proteomics Reagents-Chromatography Reagents-USA
6.1.1.7 Proteomics Reagents-Protein Fractionation Reagents-USA
6.1.2 Proteomics Reagents-USA, By Applications
6.1.2.1 Proteomics Reagents-USA-Diagnosis
6.1.2.2 Proteomics Reagents-USA-Drug Discovery
6.2 Proteomics Reagents-Canada
6.2.1 Proteomics Reagents-Canada, By Technologies
6.2.1.1 Proteomics Reagents-Protein Microarray Reagents-Canada
6.2.1.2 Proteomics Reagents-Spectroscopy Reagents-Canada
6.2.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Canada
6.2.1.4 Proteomics Reagents-Electrophoresis Reagents-Canada
6.2.1.5 Proteomics Reagents-Immunoassay Reagents-Canada
6.2.1.6 Proteomics Reagents-Chromatography Reagents-Canada
6.2.1.7 Proteomics Reagents-Protein Fractionation Reagents-Canada
6.2.2 Proteomics Reagents-Canada, By Applications
6.2.2.1 Proteomics Reagents-Canada-Diagnosis
6.2.2.2 Proteomics Reagents-Canada-Drug Discovery
Please fill in the form below to receive a free copy of the Summary of this Report
Custom Market Research Services
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Proteomics The North American Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.7 billion in 2012 and is expected to be $ 7.49 billion by 2018, at a CAGR of 12.4%. The report “North American Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, Water Corporation, etc. |
Upcoming |
|
|
European Proteomics The European Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.28 billion in 2012 and is expected to be $ 7.35 billion by 2018, at a CAGR of 14.6%. The report “European Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Roche, etc. |
Upcoming |
|
|
Asian Proteomics The Asian Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 1.42 billion in 2012 and is expected to be $ 4.16 billion by 2018, at a CAGR of 19.8%. The report “Asian Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Water Corporation, Roche, etc. |
Upcoming |
reports |
Show
Proteomics
